Host Directed Medical Countermeasures
Due: April 17, 2026 CPE CBRND is conducting essential market research for the Host-Directed Therapeutics (HD TX) program, a new initiative expected to launch in Fiscal Year 2027. This program is dedicated to identifying and Read More